Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford). 2019 07 01; 58(7):1259-1267.
-
Adolescent
-
Adolescent
-
Adult
-
Adult
-
Antiphospholipid Syndrome
-
Antiphospholipid Syndrome
-
Cohort Studies
-
Cohort Studies
-
Contraceptives, Oral, Combined
-
Contraceptives, Oral, Combined
-
Contraceptives, Oral, Hormonal
-
Contraceptives, Oral, Hormonal
-
Contraindications, Drug
-
Contraindications, Drug
-
Drug Utilization
-
Drug Utilization
-
Educational Status
-
Educational Status
-
Female
-
Female
-
Humans
-
Humans
-
Hypertension
-
Hypertension
-
Lupus Erythematosus, Systemic
-
Lupus Erythematosus, Systemic
-
Migraine with Aura
-
Migraine with Aura
-
Practice Patterns, Physicians'
-
Practice Patterns, Physicians'
-
Registries
-
Registries
-
Risk Factors
-
Risk Factors
-
Severity of Illness Index
-
Severity of Illness Index
-
Young Adult
-
Young Adult